Table of Contents
Overview
New York, NY – June 30, 2025 – Global Intrauterine Contraceptive Devices (IUD) Market size is expected to be worth around US$ 9.4 Billion by 2034 from US$ 6.5 Billion in 2024, growing at a CAGR of 3.8% during the forecast period 2025 to 2034. In 2024, North America led the market, achieving over 39.6% share with a revenue of US$ 2.6 Billion.
The global market for Intrauterine Contraceptive Devices (IUDs) is experiencing consistent growth, driven by increasing awareness of long-acting reversible contraceptive methods, favorable government initiatives, and rising demand for effective family planning solutions. IUDs, which include hormonal and copper-based devices, are widely recognized for their high efficacy, extended duration of use, and minimal maintenance requirements.
IUD adoption is expanding across both developed and emerging economies due to supportive reproductive health policies and growing public health efforts aimed at reducing unplanned pregnancies. The World Health Organization (WHO) and other global health bodies advocate IUDs as a safe and cost-effective option for long-term contraception. According to WHO, IUDs are more than 99% effective and can last up to 10 years depending on the type.
North America and Europe currently lead the IUD market due to well-established healthcare infrastructures and greater access to reproductive services. However, Asia-Pacific is expected to register the fastest growth rate during the forecast period, driven by rising healthcare awareness, government-led population control programs, and improved access to gynecological care.
As healthcare providers and policymakers continue to emphasize contraceptive education and accessibility, the IUD market is poised for substantial expansion. Advances in device design, increased outreach programs, and regulatory approvals are expected to further boost market penetration and acceptance globally.
Key Takeaways
- In 2024, the global Intrauterine Contraceptive Devices (IUD) market recorded a total revenue of US$ 6.5 billion, and it is projected to grow at a compound annual growth rate (CAGR) of 3.8%, reaching approximately US$ 9.4 billion by 2033.
- Based on type, the market is segmented into hormonal IUDs and copper IUDs. In 2023, hormonal IUDs dominated the market, accounting for 57.3% of the total share, due to their effectiveness and longer duration of action.
- By distribution channel, the market is categorized into hospitals, gynecology clinics, and others. Among these, hospitals held the largest share, contributing 52.8% of total revenue in 2023, driven by the availability of skilled professionals and advanced infrastructure.
- Regionally, North America emerged as the leading market in 2023, capturing 39.6% of the global market share, supported by strong healthcare systems, high awareness of contraceptive methods, and favorable reimbursement policies.
Segmentation Analysis
- Type Analysis: In 2023, hormonal IUDs accounted for 57.3% of the market share, driven by their dual benefits of long-term contraception and additional health advantages. These devices are effective in reducing menstrual bleeding and alleviating period pain, making them a preferred choice among women. With rising awareness and demand for long-acting reversible contraception, hormonal IUDs are expected to witness sustained growth. Their convenience and role in personalized healthcare further enhance their appeal over other birth control methods.
- Distribution Channel Analysis: Hospitals captured a 52.8% market share, establishing themselves as the leading distribution channel for IUDs in 2023. This dominance is supported by the availability of specialized medical professionals, counseling services, and comprehensive reproductive care. Hospitals offer safe and personalized environments for women to access long-term contraceptive solutions. With the ongoing expansion of maternal and reproductive health services, particularly in developed healthcare systems, hospitals are expected to maintain their pivotal role in IUD distribution globally.
Market Segments
By Type
- Hormonal IUD
- Copper IUD
By Distribution Channel
- Hospital
- Gynecology Clinics
- Others
Regional Analysis
North America led the global intrauterine contraceptive devices (IUD) market in 2023, securing the highest revenue share of 39.6%. This growth is driven by increasing awareness of IUDs as effective, long-term contraceptive methods. According to the CDC’s National Center for Health Statistics (NCHS), there has been a noticeable rise in the use of long-acting reversible contraception (LARC), including IUDs, across the United States.
Recommendations from the American College of Obstetricians and Gynecologists (ACOG) further support this trend by highlighting IUDs as safe, effective, and suitable for a wide range of women, including adolescents. The availability of both hormonal and non-hormonal IUDs has enhanced their acceptance among patients and healthcare providers.
The Asia Pacific region is expected to record the highest compound annual growth rate (CAGR) during the forecast period. This growth is fueled by rising population levels, expanding family planning initiatives, and greater governmental support. Countries such as India and China have integrated IUDs into national reproductive health programs due to their cost-effectiveness. The World Health Organization (WHO) actively supports IUD use in the region, reinforcing efforts to expand access to a range of safe contraceptive options and promote informed family planning decisions.
Emerging Trends
- The use of long-acting reversible contraception (LARC), which includes IUDs, has risen from 8.0 % to 11.3 % among U.S. women aged 15–44 between 2011–2015 and 2015–2017.
- Among U.S. girls aged 15–19, LARC adoption reached 19 % in 2015–2019 a threefold increase over 2011–2015 reflecting greater access and education.
- Post-placental and intra-cesarean IUD insertion (PPIUCD) has gained attention: 68.7 % of women were aware of PPIUCD, though only 30.0 % consented to insertion in one study.
- Task-sharing policies have allowed nurse-midwives and auxiliary providers to perform IUD insertions, expanding service capacity in low-resource settings.
- The typical-use failure rate for IUDs remains below 1 %, underscoring their high reliability compared with short-term methods.
Use Cases
- Long-Term Pregnancy Prevention: IUDs are reversible and, with fewer than 1 pregnancy per 100 users in the first year, they offer highly dependable, low-maintenance contraception.
- Emergency Contraception: A copper IUD may be placed within 5 days after unprotected intercourse as emergency contraception, providing ongoing protection without additional backup needed.
- Immediate Postpartum Control: Copper IUDs may be inserted immediately after childbirth or abortion without the need for backup methods, facilitating timely fertility management.
- Adolescent and Young Adult Use: Increasing education and service availability have driven IUD uptake among teens, with 19 % of girls 15–19 using LARC in 2015–2019.
Conclusion
The global intrauterine contraceptive devices (IUD) market is witnessing steady growth, driven by increasing awareness of long-acting contraceptive options, government-led reproductive health initiatives, and rising demand for effective, low-maintenance birth control. With high efficacy rates, minimal failure, and added health benefits, IUDs are gaining acceptance across all age groups.
North America leads the market, while Asia Pacific shows the fastest growth potential. Support from organizations like WHO and ACOG, alongside innovative service delivery models and expanded access, is expected to drive continued adoption. The market outlook remains strong as personalized and accessible family planning solutions gain global momentum.
Discuss your needs with our analyst
Please share your requirements with more details so our analyst can check if they can solve your problem(s)
